in the morning of july 5th, 2019, the director of shanghai food and drug administration, wen daxiang, deputy director, guo shuyan and deputy head of district, lu zufang visted shanghai kindly medical instruments limited corporation in a group to know about the corporation’s operation condition and potential issues. director wen, together with his group members browsed our whole operational chain including exhibition area, products r&d zone, mould r&d zone, packing and sterilization zone. chairman dr. liang introduced the operating, products innovation, qa and marketing condition afterwards. director wen addressed that bio-pharmacy sector is one of shanghai’s leading and specialized sectors, and shanghai kindly medical instruments should continue emphasizing on r&d, attracting both domestic and overseas talents in joining the team, and making contribution to shanghai’s bio-pharmacy sector with the support of jiading government. director wen encouraged our company to adhere the vision of “serve health industry with innovative technology, achieve market success with high quality products!”, and support the development of chinese medical instruments industry with developing more ips and higher cp products, and eventually increase the acceptance level of chinese medical instruments in overseas market.